Emily J. Cicali, Pharm.D.

Emily J. Cicali

Clinical Assistant Professor

Pharmacotherapy and Translational Research

OFFICE: MSB DG-22R

EMAIL: emily.cicali@cop.ufl.edu

PHONE: 352-273-7919

CV: Link to CV

 

Emily Cicali, Pharm.D., received her Doctor of Pharmacy degree from Philadelphia College of Pharmacy, University of the Sciences in 2015. She then completed a Pharmacy Practice Residency at Tabula Rasa HealthCare in Geriatric Personalized Medicine. After her residency, she was hired to work Tabula Rasa HealthCare at as a Research Pharmacist, as well as adjunct faculty at the Philadelphia College of Pharmacy, focusing on clinical pharmacokinetics and pharmacogenomics implementation. In 2017 she decided to fully transition to academia, which led to her completion of a fellowship in pharmacogenomics at the University of Florida. Cicali is now a Clinical Assistant Professor in the Department of Pharmacotherapy and Translational Research. Her clinical practice is within the UF Health Personalized Medicine Program and her research interests include clinical implementation of pharmacogenomics as well as further understanding the role of phenoconversion for optimal medication safety.

Education

  • BS in pharmaceutical and Healthcare Studies, Philadelphia College of Pharmacy, University of the Sciences
  • PharmD, Philadelphia College of Pharmacy, University of the Sciences
  • Pharmacy Practice Residency in Geriatric Personalized Medicine and Targeted Therapeutics, Tabula Rasa HealthCare
  • Pharmacogenomics Fellowship, University of Florida, College of Pharmacy

Affiliations

  • 2017–present: American College of Clinical Pharmacy (ACCP)
  • 2016–present: Clinical Pharmacogenetics Implementation Consortium (CPIC)
  • 2015–present: American Society of Clinical Pharmacology and Therapeutics (ASCPT)
  • 2015–present: Pharmacogenomics Research Network (PGRN)

 

Research Interest

  • Clinical implementation of pharmacogenomics
  • Pharmacokinetic changes caused by CYP-inhibitors (phenoconversion)
  • Survey research to patients and prescribers to determine attitudes and acceptability of pharmacogenomics

Publications

  1. Cicali EJ, Weitzel KW, Elsey AR, Orlando FA, Vinson M, Mosley S, Smith DM, Davis R, Drum L, Estores D, Franciosi JP, Hagen MG, Jerkins GJ, Mercado ES, Nainaparampil J, Padron A, Rosenberg EI, Wright A, Schmidt SO, Mathews CA, Cavallari LH, Johnson JA. Challenges and lessons learned from clinical pharmacogenetic implementation of multiple gene-drug pairs across ambulatory care settings. Genet Med. 2019 Mar 30. [Epub ahead of print]
  2. Orlando LA, Voils C, Horowitz CR, Myers RA, Arwood MJ, Cicali EJ, McDonough CW, Pollin TI, Guan Y, Levy KD, Ramirez A, Quittner A, Madden EB. IGNITE network: Response of patients to genomic medicine interventions. Mol Genet Genomic Med. 2019 May;7(5):e636.
  3. Cicali EJ, Blake K, Gong Y, Mougey EB, Al-Atrash H, Chambers N, Denham J, Evans J, George DE, Gomez R, Palomo P, Taufiq S, Johnson JA, Lima JJ, Franciosi JP. Novel Implementation of Genotype-Guided Proton Pump Inhibitor Medication Therapy in Children: A Pilot, Randomized, Multisite Pragmatic Trial. Clin Transl Sci. 2019 Mar;12(2):172-179.
  4. Bain KT, Schwartz EJ, Knowlton OV, Knowlton CH, Turgeon J. Implementation of a Pharmacist-Led Pharmacogenomics Service for PACE (PHARM-GENOME-PACE). J Am Pharm Assoc. 2018 Mar 27. piiSE1544-3191(18):30076-1.
  5. Schwartz EJ, Turgeon J, Patel J, Patel P, Shah H, Issa AM, Knowlton OV, Knowlton CH, Bain KT. Successful Implementation of a Standardized Medication Therapy Management Plus Approach within a Primary Care Setting. J of Amer Board of Family Medicine. 2017 November-December; 30: 701-14.
  6. Bain KT, Schwartz EJ, Chan-Ting R. Reducing Off-Label Antipsychotic Use in Community-Dwelling Older Adults with Dementia: A Narrative Review. J Am Osteopath Assoc. 2017 July; 117:441-50.
  7. Schwartz EJ, Issa AM. The Role of Hospital Pharmacists in the Adoption and Use of Pharmacogenomics and Precision Medicine. Personalized Medicine. Epub 2016 Oct 18.